Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Review
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,413 | Dovepress* | 12,419+ | 1,305 | 13,724 | |
| PubMed Central* | 1,994 | 799 | 2,793 | ||
| Totals | 14,413 | 2,104 | 16,517 | ||
| *Since 10 July 2017 | |||||
View citations on PubMed Central and Google Scholar